TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Novo Nordisk Pharmatech A/S
Closing information (x1000 NOK)
Closing information | 2022/12 | 2021/12 | 2020/12 |
Turnover | 846,870 | 830,309 | 943,809 |
Earnings before taxes | 69,723 | 196,763 | 206,604 |
Total assets | 1,368,708 | 858,260 | 1,053,770 |
Current assets | 713,031 | 331,305 | 538,840 |
Current liabilities | 331,564 | 121,430 | 153,532 |
Equity capital | 976,185 | 697,751 | 857,171 |
- share capital | 14,157 | 13,412 | 14,135 |
Employees (average) | 150 | 150 | 150 |
Financial ratios
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Solvency | 71.3% | 81.3% | 81.3% |
Turnover per employee | 5,646 | 5,535 | 6,292 |
Profit as a percentage of turnover | 8.2% | 23.7% | 21.9% |
Return on assets (ROA) | |||
Current ratio | 215.1% | 272.8% | 351.0% |
Return on equity (ROE) | 7.1% | 28.2% | 24.1% |
Change turnover | -29,469 | -65,244 | 66,061 |
Change turnover % | -3% | -7% | 8% |
Chg. No. of employees | 0 | 0 | 0 |
Chg. No. of employees % | 0% | 0% | 0% |
Total value of public sale
Fiscal year | 2022/12 | 2021/12 | 2020/12 |
Total value of public sale | 0 | 0 | 0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.